Probation disproportionately affects the health outcomes of Black Americans

“Mistrust all in whom the impulse to punish is powerful,” warned Friedrich Nietzsche more than a century ago.

FDA grants fast track status for Ambrx’s prostate cancer treatment

APEX-01 is enrolling patients with tumours that have advanced following treatment with a minimum of two FDA-approved prostate cancer therapies. Credit: Peakstock / shutterstock.com. The

July 20, 2023

Mixed Results With Senolytic Agent for Retinal Disease

SEATTLE — A drug targeting senescent cells in diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD) produced mixed outcomes in two separate clinical

August 3, 2023

AI model predicts future spread of SARS-CoV-2 variants using genomic data

Researchers developed an AI-based model to predict the spread of new SARS-CoV-2 variants, analyzing nine million genomic sequences across 30 countries and incorporating factors like

January 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.